Books on the topic 'Endpoints'

To see the other types of publications on this topic, follow the link: Endpoints.

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 books for your research on the topic 'Endpoints.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse books on a wide variety of disciplines and organise your bibliography correctly.

1

Bradshaw, A. D. Alternative endpoints for reclamation. Boca Raton, FL: CRC Press, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Burzykowski, Tomasz, Geert Molenberghs, and Marc Buyse, eds. The Evaluation of Surrogate Endpoints. New York, NY: Springer New York, 2005. http://dx.doi.org/10.1007/b138566.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Emura, Takeshi, Shigeyuki Matsui, and Virginie Rondeau. Survival Analysis with Correlated Endpoints. Singapore: Springer Singapore, 2019. http://dx.doi.org/10.1007/978-981-13-3516-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Rauch, Geraldine, Svenja Schüler, and Meinhard Kieser. Planning and Analyzing Clinical Trials with Composite Endpoints. Cham: Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-73770-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sozu, Takashi, Tomoyuki Sugimoto, Toshimitsu Hamasaki, and Scott R. Evans. Sample Size Determination in Clinical Trials with Multiple Endpoints. Cham: Springer International Publishing, 2015. http://dx.doi.org/10.1007/978-3-319-22005-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Clinical trials: Study design, endpoints and biomarkers, drug safety, FDA and ICH guidelines. Amsterdam: Elsevier/AP, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Medicine), Roundtable for the Development of Drugs and Vaccines against AIDS (Institute of. Surrogate endpoints in evaluating the effectiveness of drugs against HIV infection and AIDS: September 11-12, 1989 : conference summary. Washington, D.C: National Academy Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Morganroth, Joel, and E. Neil Moore, eds. Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia. Boston, MA: Springer US, 1990. http://dx.doi.org/10.1007/978-1-4613-1505-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

John, Updike. Endpoint and other poems. New York: Alfred A. Knopf, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

John, Updike. Endpoint and Other Poems. New York: Knopf Doubleday Publishing Group, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
11

John, Updike. Endpoint and other poems. New York: Alfred A. Knopf, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
12

Workshop on New Approaches, Endpoints and Paradigms for RDAs of Mineral Elements (1995 Grand Forks, N.D.). Workshop on New Approaches, Endpoints and Paradigms for RDAs of Mineral Elements: Proceedings from a workshop held in Grand Forks, ND on September 10-12, 1995. Bethesda, MD: American Institute of Nutrition, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
13

Bedard, D. Evaluation of the 10-day sediment toxicity test using the midge (Chironomus tentans): The effect of different water-sediment ratios on biological endpoints and water quality. [Toronto]: Ontario Ministry of Environment and Energy, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
14

Workshop, on New Approaches Endpoints and Paradigms for RDAs of Mineral Elements (1995 Grand Forks N. D. ). Workshop on New Approaches, Endpoints and Paradigms for RDAs of Mineral Elements: Proceedings from a workshop held in Grand Forks, ND on September 10-12, 1995. Bethesda, MD: American Institute of Nutrition, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
15

The Evaluation Of Surrogate Endpoints. Springer, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
16

Molenberghs, Geert, Marc Buyse, and Tomasz Burzykowski. The Evaluation of Surrogate Endpoints. Springer, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
17

Wagner, J. A. Surrogate Endpoints in Medicine (Disease Markers). Ios Pr Inc, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
18

Downing, G. J. Biomarkers and Surrogate Endpoints: Clinical Research and Applications. Elsevier, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
19

Rauch, Geraldine, Svenja Schüler, and Meinhard Kieser. Planning and Analyzing Clinical Trials with Composite Endpoints. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
20

Rauch, Geraldine, Svenja Schüler, and Meinhard Kieser. Planning and Analyzing Clinical Trials with Composite Endpoints. Springer, 2018.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
21

Evaluation Of Biomarkers And Surrogate Endpoints In Chronic Disease. National Academies Press, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
22

Emura, Takeshi, Shigeyuki Matsui, and Virginie Rondeau. Survival Analysis with Correlated Endpoints: Joint Frailty-Copula Models. Springer, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
23

Emura, Takeshi. Survival Analysis with Correlated Endpoints: Joint Frailty-Copula Models. Springer, 2019.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
24

United States. Environmental Protection Agency. Risk Assessment Forum., ed. Generic ecological assessment endpoints (GEAEs) for ecological risk assessment. Washignton, DC: Risk Assessment Forum, U.S. Environmental Protection Agency, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
25

G, Chapman, and United States. Environmental Protection Agency, eds. Discussion synopsis: Effluent toxicity testing methods and appropriate endpoints. [Washington, D.C.?: U.S. Environmental Protection Agency, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
26

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease. Washington, D.C.: National Academies Press, 2010. http://dx.doi.org/10.17226/12869.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

(Editor), Tomasz Burzykowski, Geert Molenberghs (Editor), and Marc Buyse (Editor), eds. The Evaluation of Surrogate Endpoints (Statistics for Biology and Health). Springer, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
28

1941-, Peace Karl E., ed. Design and analysis of clinical trials with time-to-event endpoints. Boca Raton: Chapman & Hall/CRC/Taylor & Francis, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
29

Design and Analysis of Clinical Trials with Time-to-Event Endpoints. Chapman & Hall/CRC, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
30

Peace, Karl E. Design and Analysis of Clinical Trials with Time-To-Event Endpoints. Taylor & Francis Group, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
31

Peace, Karl E., ed. Design and Analysis of Clinical Trials with Time-to-Event Endpoints. Chapman and Hall/CRC, 2009. http://dx.doi.org/10.1201/9781420066401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Brody, Tom. Clinical Trials: Study Design, Endpoints and Biomarkers, Drug Safety, and FDA and ICH Guidelines. Elsevier Science & Technology Books, 2016.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
33

Jörg, Römbke, and SETAC (Society), eds. Effects of plant protection products on functional endpoints in soil (EPFES), Lisbon, 24-26 April 2002. Pensacola, FL: Society of Environmental Toxicology and Chemistry, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
34

Hardy, Bruce W., and Kathleen Hall Jamieson. Overcoming Biases in Processing of Time Series Data About Climate. Edited by Kathleen Hall Jamieson, Dan M. Kahan, and Dietram A. Scheufele. Oxford University Press, 2017. http://dx.doi.org/10.1093/oxfordhb/9780190497620.013.43.

Full text
Abstract:
This chapter notes the important ways in which time series data are used in science, explains how trend lines are created and reported, chronicles ways in which they can be misused, documents human biases that lead to overvaluing endpoints in a trend, and outlines ways to minimize that bias. Specifically, this chapter defines trend lines and time series data and explain why and how they matter in science communication. A discussion on cognitive biases that influence interpretations of trend lines, such as endpoint bias and peak and end rule, recency bias, accessibility bias, and extrapolation bias, is offered as are communication tools scientists, journalists, and other science communicators can use to overcome these biases.
APA, Harvard, Vancouver, ISO, and other styles
35

Kulkarni, Kunal, James Harrison, Mohamed Baguneid, and Bernard Prendergast, eds. Transplantation. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780198729426.003.0030.

Full text
Abstract:
Organ transplantation is now a well-established therapy for patients with end-stage organ failure. Over the last 20 years, the results of transplantation have improved incrementally for many reasons, including better recipient selection, improved anaesthetic and surgical techniques, the introduction of more effective antiviral agents, and better post-transplant immunosuppressive management. The problem of early graft loss from acute rejection is now uncommon, and the main challenges today are chronic allograft rejection and the side effects of non-specific suppression of the immune response. Randomized clinical trials continue to inform and further improve clinical practice. Because transplantation today is largely successful, the traditional endpoints of 1-year patient and graft survival are no longer sufficient, and more sophisticated endpoints are needed that reflect graft function and quality of life after transplantation. This chapter brings together studies which recognize this need for clinical trials which improve practice and focus on more broadly defined endpoints.
APA, Harvard, Vancouver, ISO, and other styles
36

American Academy of Environmental Engineers (Corporate Author), David G. Linz (Editor), and David V. Nakles (Editor), eds. Environmentally Acceptable Endpoints in Soil: Risk-Based Approach to Contaminated Site Management Based on Availability of Chemicals in Soil. Amer Academy of Environmental, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
37

G, Linz David, Nakles David V, and American Academy of Environmental Engineers., eds. Environmentally acceptable endpoints in soil: Risk-based approach to contaminated site management based on availability of chemicals in soil. Annapolis, MD: American Academy of Environmental Engineers, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
38

Endpoint Security. Addison-Wesley Professional, 2007.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
39

Morganroth, J. Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Drugs Affecting Antiarrhythmic Heart Failure and Hypolipidemia. Springer, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
40

Humane endpoints in animal experiments for biomedical research: Proceedings of the international conference, 22-25 November 1998, Zeist, the Netherlands. London: Royal Society of Medicine Press, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
41

Guidance Document on the Recognition, Assessment and Use of Clinical Signs as Human Endpoints for Experimental Animals Used in Safety Evaluation. OECD, 2002. http://dx.doi.org/10.1787/9789264078376-en.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Skin Endpoint Titration. 2nd ed. Thieme-Stratton Corp, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
43

L, Mabry Richard, ed. Skin endpoint titration. 2nd ed. New York: Thieme Medical Publishers, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
44

Kipnis, Eric, and Benoit Vallet. Tissue perfusion monitoring in the ICU. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0138.

Full text
Abstract:
Resuscitation endpoints have shifted away from restoring normal values of routinely assessed haemodynamic parameters (central venous pressure, mean arterial pressure, cardiac output) towards optimizing parameters that reflect adequate tissue perfusion. Tissue perfusion-based endpoints have changed outcomes, particularly in sepsis. Tissue perfusion can be explored by monitoring the end result of perfusion, namely tissue oxygenation, metabolic markers, and tissue blood flow. Tissue oxygenation can be directly monitored locally through invasive electrodes or non-invasively using light absorbance (pulse oximetry (SpO2) or tissue (StO2)). Global oxygenation may be monitored in blood, either intermittently through blood gas analysis, or continuously with specialized catheters. Central venous saturation (ScvO2) indirectly assesses tissue oxygenation as the net balance between global O2 delivery and uptake, decreasing when delivery does not meet demand. Lactate, a by-product of anaerobic glycolysis, increases when oxygenation is inadequate, and can be measured either globally in blood, or locally in tissues by microdialysis. Likewise, CO2 (a by-product of cellular respiration) and PCO2 can be measured globally in blood or locally in accessible mucosal tissues (sublingual, gastric) by capnography or tonometry. Increasing PCO2 gradients, either tissue-to-arterial or venous-to-arterial, are due to inadequate perfusion. Metabolically, the oxidoreductive status of mitochondria can be assessed locally through NADH fluorescence, which increases in situations of inadequate oxygenation/perfusion. Finally, local tissue blood flow may be measured by laser-Doppler or visualized through intravital microscopic imaging. These perfusion/oxygenation resuscitation endpoints are increasingly used and studied in critical care.
APA, Harvard, Vancouver, ISO, and other styles
45

J, Raiten Daniel, and Talbot John M, eds. Clinical trials for the treatment of secondary wasting and cachexia: Selection of appropriate endpoints : proceedings of a workshop, May 22-23, 1997. Bethesda, MD: American Society for Nutritional Sciences, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
46

J, Raiten Daniel, and Talbot John M, eds. Clinical trials for the treatment of secondary wasting and cachexia: Selection of appropriate endpoints : proceedings of a workshop, May 22-23, 1997. Bethesda, MD: American Society for Nutritional Sciences, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
47

Peake, Sandra L., and Matthew J. Maiden. Management of septic shock in the critically ill. Oxford University Press, 2016. http://dx.doi.org/10.1093/med/9780199600830.003.0298.

Full text
Abstract:
The management of septic shock is a medical emergency. Following prompt recognition, treatment priorities are haemodynamic resuscitation, empirical antimicrobials, urgent control of the source of infection and monitoring the response to therapy. Haemodynamic resuscitation is focused on maintaining an adequate macrocirculation, while also ensuring adequacy of microcirculatory blood flow to the cells. Intravenous fluids and catecholamines have been the mainstay of therapy. However, the amount and type of fluids, choice of vasoactive medications, and the appropriate resuscitation endpoints have been questioned. Greater awareness of the importance of resuscitating the microcirculation and cell function have led to endpoints such as venous O2 saturation and changes in lactate levels becoming resuscitation targets. Urgent definitive treatment of the infection is also crucial. This requires prompt broad-spectrum empirical antimicrobial therapy, draining infected collections and removing infected medical devices. Despite extensive research, no new therapies have improved survival from septic shock.
APA, Harvard, Vancouver, ISO, and other styles
48

Pascual, J. Using Patient-Friendly Composite Endpoints to Measure the Success of Acute Migraine Medications: 4th Annual Migraine Meeting, Budapest, October 2004: Proceedings (European Neurology). Edited by J. Pascual. S. Karger A. G., 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
49

Use and Approval of Antihypertensive Agents and Surrogate Endpoints for the Approval of Antiarrhythmic, Antiheart Failure and Hypolipidemic Agents (Developments in Cardiovascular Medicine). Springer, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
50

Cassidy, Jim, Donald Bissett, Roy A. J. Spence OBE, Miranda Payne, and Gareth Morris-Stiff. Cancer prevention. Oxford University Press, 2018. http://dx.doi.org/10.1093/med/9780199689842.003.0011.

Full text
Abstract:
Introduces the reader to importance of clinical trials in cancer therapy. Describes the phases of development and some of the “traditional” guidelines for such studies. Focuses particularly on early phase trials of novel compounds. Also describes endpoints used in such trials. Section on quality of life which highlights the growing importance of this aspect of trail design and interpretation
APA, Harvard, Vancouver, ISO, and other styles
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography